Log in

Relevant bibliographies by topics / Lipoprotein(a)-cholesterol

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Lipoprotein(a)-cholesterol'

Author: Grafiati

Published: 4 June 2025

Last updated: 1 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Lipoprotein(a)-cholesterol.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Lipoprotein(a)-cholesterol"

1

Paré, Guillaume, Michael Chong, and Pedrum Mohammadi-Shemirani. "Lipoprotein(a) Cholesterol Masquerading as Low-Density Lipoprotein Cholesterol." Journal of the American College of Cardiology 79, no. 11 (2022): 1047–49. http://dx.doi.org/10.1016/j.jacc.2022.01.014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Katsiki, Niki, Michal Vrablik, Maciej Banach, and Ioanna Gouni-Berthold. "Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)." Pharmaceuticals 16, no. 4 (2023): 577. http://dx.doi.org/10.3390/ph16040577.

Full text

Abstract:

Dyslipidemia treatment is of major importance in reducing the risk of atherosclerotic cardiovascular disease (ASCVD), which is still the most common cause of death worldwide. During the last decade, a novel lipid-lowering drug category has emerged, i.e., proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. Apart from the two available anti-PCSK9 monoclonal antibodies (alirocumab and evolocumab), other nucleic acid-based therapies that inhibit or “silence” the expression of PCSK9 are being developed. Among them, inclisiran is the first-in-class small interfering RNA (siRNA) against

APA, Harvard, Vancouver, ISO, and other styles

3

Bacquer, Dirk De, Delphine De Smedt, Željko Reiner, et al. "Percentage low-density lipoprotein-cholesterol response to a given statin dose is not fixed across the pre-treatment range: Real world evidence from clinical practice: Data from the ESC-EORP EUROASPIRE V Study." European Journal of Preventive Cardiology 27, no. 15 (2019): 1630–36. http://dx.doi.org/10.1177/2047487319874898.

Full text

Abstract:

Aims Recent European guidelines recommend in patients with atherosclerotic cardiovascular disease to achieve a reduction of low-density lipoprotein-cholesterol of at least 50% if the baseline low-density lipoprotein-cholesterol level is between 1.8 and 3.5 mmol/L. Systematic reviews have associated a given statin/dose combination with a fixed percentage low-density lipoprotein-cholesterol response. Algorithms for detecting cases and estimating the prevalence of familial hypercholesterolaemia often rely on such fixed percentage reductions. Methods and results We used data from 915 coronary pati

APA, Harvard, Vancouver, ISO, and other styles

4

Kinpara, Kiyoko, Hiroshi Okada, Akiko Yoneyama, Minoru Okubo, and Toshio Murase. "Lipoprotein(a)-cholesterol: A significant component of serum cholesterol." Clinica Chimica Acta 412, no. 19-20 (2011): 1783–87. http://dx.doi.org/10.1016/j.cca.2011.05.036.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Yeang, Calvin, Ewa Karwatowska-Prokopczuk, Fei Su, et al. "Effect of Pelacarsen on Lipoprotein(a) Cholesterol and Corrected Low-Density Lipoprotein Cholesterol." Journal of the American College of Cardiology 79, no. 11 (2022): 1035–46. http://dx.doi.org/10.1016/j.jacc.2021.12.032.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Vallejo-Vaz, Antonio J., Lawrence A. Leiter, Stefano Del Prato, et al. "Triglyceride concentrations and non-high-density lipoprotein cholesterol goal attainment in the ODYSSEY phase 3 trials with alirocumab." European Journal of Preventive Cardiology 27, no. 15 (2020): 1663–74. http://dx.doi.org/10.1177/2047487320905185.

Full text

Abstract:

Aims Guidelines recommend targeting non-high-density lipoprotein cholesterol to reduce cardiovascular risk. We assessed the impact of baseline triglycerides on non-high-density lipoprotein cholesterol goal attainment in 10 phase 3 trials with alirocumab versus control ( n = 4983). Methods Trials were grouped into four pools based on alirocumab dose (75–150 mg every 2 weeks), control (placebo/ezetimibe) and statin use. Baseline triglyceride quintiles were built within each pool. Non-high-density lipoprotein cholesterol goal attainment (very high risk: <100 mg/dl; moderate/high risk: <130

APA, Harvard, Vancouver, ISO, and other styles

7

Ahmed, Munir. "CORONARY HEART DISEASE;." Professional Medical Journal 21, no. 06 (2014): 1171–73. http://dx.doi.org/10.29309/tpmj/2014.21.06.2250.

Full text

Abstract:

Objective: This study was done to find any correlation among total cholesterol, triglycerides, low density lipoprotein cholesterol and high density lipoprotein cholesterol estimated in serum of offsprings of coronary heart disease patients. Study Design: A cross sectional comparative study. Patients and Methods: Two hundred and fifty (250) subjects having parents with coronary heart disease were selected from Punjab Institute of Cardiology Lahore. The serum total cholesterol, triglycerides, low density lipoprotein cholesterol, and high density lipoprotein cholesterol were estimated. Coefficien

APA, Harvard, Vancouver, ISO, and other styles

8

Whyte, Martin B. "Is high-density lipoprotein a modifiable treatment target or just a biomarker for cardiovascular disease?" JRSM Cardiovascular Disease 8 (January 2019): 204800401986973. http://dx.doi.org/10.1177/2048004019869736.

Full text

Abstract:

Epidemiological data strongly support the inverse association between high-density lipoprotein cholesterol concentration and cardiovascular risk. Over the last three decades, pharmaceutical strategies have been partially successful in raising high-density lipoprotein cholesterol concentration, but clinical outcomes have been disappointing. A recent therapeutic class is the cholesteryl ester transfer protein inhibitor. These drugs can increase circulating high-density lipoprotein cholesterol levels by inhibiting the exchange of cholesteryl ester from high-density lipoprotein for triacylglycerol

APA, Harvard, Vancouver, ISO, and other styles

9

Chen, Ouxiang, Qian Sun, Wenjie Liu, Ming Hong, and Sixuan Qian. "A Combination of Enteral Nutritional Support and Induction Therapy Elevates Blood Lipids, Improves Nutritional Status, and Increases Longer Overall Survival in Acute Myeloid Leukemia." Current Topics in Nutraceutical Research 22, no. 1 (2023): 74–84. http://dx.doi.org/10.37290/ctnr2641-452x.22:74-84.

Full text

Abstract:

This study aimed to explore the changes in blood lipids and nutritional indexes in acute myeloid leukemia patients before and after enteral nutritional support combined with induction therapy and assess the influences of blood lipids on prognosis. The clinical data from 210 patients with initial treatment results were retrospectively analyzed. Total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol are lower in acute myeloid leukemia patients compared to normal controls, while triglyceride levels are higher. Total cholesterol and low-density lipoprotein

APA, Harvard, Vancouver, ISO, and other styles

10

Tambalis, Konstantinos, Demosthenes B. Panagiotakos, Stavros A. Kavouras, and Labros S. Sidossis. "Responses of Blood Lipids to Aerobic, Resistance, and Combined Aerobic with Resistance Exercise Training: A Systematic Review of Current Evidence." Angiology 60, no. 5 (2008): 614–32. http://dx.doi.org/10.1177/0003319708324927.

Full text

Abstract:

This review considers the effectiveness of aerobic exercise training with different intensities (moderate and high) as well as the type of exercise (aerobic, resistance, and combined aerobic with resistance) in altering the blood lipids. We reviewed various trials via a systematic search of PubMed, published reviews, and references from original articles. We selected studies that involved aerobic and/or resistance and/or combined exercise training in healthy adults over a limit of 12 weeks and had examined the response of training to one or more of the following: triglycerides, total cholester

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Lipoprotein(a)-cholesterol"

1

Wilson, Diane Lilias. "Lipoprotein oxidation and the cholesterol esterification in a human monocytic cell line." Thesis, University College London (University of London), 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.309473.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Cooke, Allison L. B. A. "The Molecular Interaction of Apolipoprotein A-I and Lecithin: Cholesterol Acyl Transferase." University of Cincinnati / OhioLINK, 2018. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1543580636448357.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Coghill, Nicola. "The effect of a walking programme on the total cholesterol to high-density lipoprotein cholesterol ratio and components of the metabolic syndrome in hyperlipidaemic men aged 45-65." Thesis, University of Bristol, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.430156.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Sun, Cathy J. "Concordance and Discordance Between Non-High-Density Lipoprotein Cholesterol and Apolipoprotein B as Cardiovascular Disease Risk Markers over the Full Spectrum of Hypertriglyceridemia: A Cross-sectional Analysis of Lipid Clinic Data." Thesis, Université d'Ottawa / University of Ottawa, 2021. http://hdl.handle.net/10393/41980.

Full text

Abstract:

Cardiovascular disease is a leading cause of morbidity and mortality worldwide. Lipid biomarkers are frequently used for prediction of cardiovascular disease risk. Triglycerides are routinely checked in blood work, and triglycerides are a key component of lipoproteins that contribute to atherogenic plaques, which cause cardiovascular disease. High triglycerides are a common condition in the general population. The relative effect of high triglycerides on the lipid biomarkers (non-high-density lipoprotein cholesterol, and apolipoprotein B) for cardiovascular disease risk prediction is the focus

APA, Harvard, Vancouver, ISO, and other styles

5

Lee, Dong-Young. "Modification of high-density lipoprotein 3 by secretory sphingomyelinase, its effects on cholesterol trafficking/ transport, and secretory sphingomyelinase as a protein biomarker for inflammatory disease." Thesis, McGill University, 2008. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=21990.

Full text

Abstract:

Secretory sphingomyelinase (S-SMase), one of the products of acid sphingomyelinase (ASM) or sphingomyelin phosphodiesterase-1 (SMPD-1) gene, hydrolyses sphingomyelin (SM) present in plasma membrane and lipoprotein particles. A number of studies have indicated that S-SMase plays an important role in intracellular or paracrine ceramide second messenger signaling pathways and development of subendothelial atherosclerotic plaque. However, a well-defined function of this enzyme in reverse cholesterol pathway (RCT) in vivo is yet to be elucidated. In this dissertation, we investigated modification

APA, Harvard, Vancouver, ISO, and other styles

6

Alghamdi, Rasha Hassen. "Development of Inhibitors of Human PCSK9 as Potential Regulators of LDL-Receptor and Cholesterol." Thesis, Université d'Ottawa / University of Ottawa, 2014. http://hdl.handle.net/10393/30492.

Full text

Abstract:

Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) is the ninth member of the Ca+2-dependent mammalian proprotein convertase super family of serine endoproteases that is structurally related to the bacterial subtilisin and yeast kexin enzymes. It plays a critical role in the regulation of lipid metabolism and cholesterol homeostasis by binding to and degrading low-density lipoprotein-receptor (LDL-R) which is responsible for the clearance of circulatory LDL-cholesterol from the blood. Owing to this functional property, there is plenty of research interest in the development of functional inhibit

APA, Harvard, Vancouver, ISO, and other styles

7

Gibran, Luciano. "A expressão de receptores de LDL em membrana celular de focos de endometriose profunda para viabilização do uso de nanoemulsão lipídica carreadora de droga antiproliferativa." Universidade de São Paulo, 2016. http://www.teses.usp.br/teses/disponiveis/5/5139/tde-04112016-111940/.

Full text

Abstract:

Objetivo: O objetivo desse estudo foi avaliar a expressão gênica e a determinação proteica de receptores de LDL (LDL-R e LRP-1) na lesão de endometriose profunda e comparar com o endométrio de mulheres com e sem endometriose, assim como determinar o perfil lipídico de pacientes com e sem endometriose profunda. Pacientes e métodos: Realizamos estudo transversal, caso-controle, exploratório com 39 pacientes, sendo 20 pacientes com diagnóstico histológico de endometriose profunda com comprometimento intestinal e 19 pacientes sem endometriose submetidas à laqueadura tubária laparoscópica. Foram co

APA, Harvard, Vancouver, ISO, and other styles

8

Hayat, Shaista. "The effect of serum amyloid A on high density lipoprotein function." Thesis, London School of Hygiene and Tropical Medicine (University of London), 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.287948.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Almeida, Cristina Pio de. "Captação celular de uma nanoemulsão semelhante a LDL (LDE): efeito da variação na composição química e expressão de receptores de lipoproteínas." Universidade de São Paulo, 2010. http://www.teses.usp.br/teses/disponiveis/5/5166/tde-22092010-132936/.

Full text

Abstract:

A nanoemulsão LDE tem composição lipídica semelhante à da LDL natural e é utilizada para estudos do metabolismo da LDL. Estudos anteriores mostraram que a LDE é captada pelas células pelo LDL-r, porém outros receptores podem estar envolvidos nesta captação, como LRP-1, CD36 e CD68. Os objetivos deste estudo foram: investigar a captação da LDE por células endoteliais, fibroblastos, monócitos, macrófagos e H292, identificar os receptores envolvidos na captação da LDE pelas mesmas células e avaliar os efeitos da modificação química da LDE sobre a estabilidade, captação celular, lipoperoxidação ce

APA, Harvard, Vancouver, ISO, and other styles

10

Yang, Kai-Sheng, and 楊凱盛. "Specific Detection of High Density Lipoprotein (HDL) Cholesterol in Whole Blood on a Dry-phase Test Strip." Thesis, 2015. http://ndltd.ncl.edu.tw/handle/s93ezt.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Lipoprotein(a)-cholesterol"

1

Kerry-Anne, Rye, ed. High density lipoprotein cholesterol: The new target ; a handbook for clinicians. 3rd ed. Sherborne Gibbs, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

A, Pearson Thomas, and Boden William E, eds. The imperative to raise low levels of high-density lipoprotein cholesterol: A better clinical strategy in the prevention and treatment of coronary artery disease. Excerpta Medica, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Lockton, John Andrew. A study of the quantitative and qualitative changes in triglyceride-rich lipoproteins inthe postprandial period and related change in high density lipoprotein cholesterol, preheparin plasma lipase activity, insulin and glucose in insulin dependent diabetis mellitus and controls. University of Manchester, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Schendel, Volker H. Vitamin C - Lipoprotein (a) - Cholesterol. Books on Demand GmbH, 2017.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Twisk, Jos, and Isabel Ferreira. Physical activity, physical fitness, and cardiovascular health. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199232482.003.0025.

Full text

Abstract:

The incidence of morbidity and mortality related to CVD is rather low in a paediatric population. Studies investigating the relationship between physical activity, physical fitness, and cardiovascular health in children and adolescents are therefore mostly limited to CVD risk factors as outcome measures. For this reason, this chapter will focus on the association of physical activity and physical fitness with CVD risk factors in children and adolescents. These risk factors can be divided into the so-called traditional CVD risk factors; that is, lipoproteins [total cholesterol, low-density lipo

APA, Harvard, Vancouver, ISO, and other styles

6

Sekhar, Rajagopal V. Dyslipidemia. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190493097.003.0047.

Full text

Abstract:

Patients infected with HIV often develop dyslipidemia. Although lipid abnormalities have been described in HIV-infected patients from the pre-combination antiretroviral therapy era, they are most striking in patients treated with antiretroviral drugs and may even be present in those not exposed to these drugs. The dyslipidemic profile in HIV includes abnormalities in lipids and lipoprotein, including hypertriglyceridemia, elevated plasma total low-density lipoprotein cholesterol concentrations, and low levels of high-density lipoprotein cholesterol. Many patients also have the phenotypic appea

APA, Harvard, Vancouver, ISO, and other styles

7

Ng, Dominic S. Familial Lecithin Cholesterol Acyl Transferase Deficiency Syndromes. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199972135.003.0034.

Full text

Abstract:

Lecithin cholesterol ester transferase (LCAT) is the sole enzyme in the circulation that mediates the esterification of free cholesterol (FC) to cholesterol ester (CE) in lipoproteins. Mutations in the LCAT gene result in one of two clinical syndromes: complete LCAT deficiency syndrome, and “fish eye disease.” The former is characterized by a broad spectrum of clinical features, including profound high-density lipoprotein (HDL) deficiency, hypertriglyceridemia, corneal opacities, anemia, neuropathies, and nephropathy. In contrast, fish eye disease patients develop severe HDL deficiency and sev

APA, Harvard, Vancouver, ISO, and other styles

8

Reiner, Željko, Olov Wiklund, and John Betteridge. Lipids. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199656653.003.0015.

Full text

Abstract:

Dyslipidaemia, particularly elevated low-density lipoprotein (LDL) cholesterol, is one of the most important risk factors for cardiovascular disease (CVD). Low concentrations of high-density lipoprotein (HDL) cholesterol are independently associated with high CVD risk, while moderately elevated triglycerides are considered to be a marker of increased CVD risk. The presence of dyslipidaemias secondary to other conditions must be excluded before beginning treatment. All patients with familial hypercholesterolaemia are at high risk and should be treated by lipid-lowering therapy. Lifestyle change

APA, Harvard, Vancouver, ISO, and other styles

9

The effect of aerobic exercise on total cholesterol, high-density lipoprotein, Apolipoprotein B, Apolipoprotein A-I, and percent body fat in adolescent females. 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

The effect of aerobic exercise on total cholesterol, high-density lipoprotein, Apolipoprotein B, Apolipoprotein A-I, and percent body fat in adolescent females. 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Lipoprotein(a)-cholesterol"

1

Kronenberg, Florian. "Lipoprotein(a)." In Prevention and Treatment of Atherosclerosis. Springer International Publishing, 2021. http://dx.doi.org/10.1007/164_2021_504.

Full text

Abstract:

AbstractLipoprotein(a) [Lp(a)] is an atherogenic lipoprotein with a strong genetic regulation. Up to 90% of the concentrations are explained by a single gene, the LPA gene. The concentrations show a several-hundred-fold interindividual variability ranging from less than 0.1 mg/dL to more than 300 mg/dL. Lp(a) plasma concentrations above 30 mg/dL and even more above 50 mg/dL are associated with an increased risk for cardiovascular disease including myocardial infarction, stroke, aortic valve stenosis, heart failure, peripheral arterial disease, and all-cause mortality. Since concentrations abov

APA, Harvard, Vancouver, ISO, and other styles

2

Nordestgaard, Børge G., and Anette Varbo. "Triglyceride-rich Lipoprotein Cholesterol (Remnant Cholesterol) as a Therapeutic Target for Cardiovascular Disease Risk." In Contemporary Cardiology. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-56514-5_8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Surnar, Bapurao, Nagesh Kolishetti, and Shanta Dhar. "A Synthetic Nanoparticle to Mimic High-Density Lipoprotein for Reverse Cholesterol Transport." In Methods in Molecular Biology. Springer US, 2025. https://doi.org/10.1007/978-1-0716-4534-5_28.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Aizawa, Koichi, Takuro Inoue, and Hiroyuki Suganuma. "A Possible Relationship between Tomatoes, Lycopene, and Level of High-Density Lipoprotein-Cholesterol." In Lycopene and Tomatoes in Human Nutrition and Health. CRC Press, 2018. http://dx.doi.org/10.1201/9781351110877-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Aras, Turgay. "Dyslipidemia Screening." In Newborn and Childhood Screening Programmes. Nobel Tip Kitabevleri, 2024. http://dx.doi.org/10.69860/nobel.9786053358961.13.

Full text

Abstract:

Dyslipidemia is lipoprotein metabolism disorders characterized by high total cholesterol (TC), LDL-C, non-HDL-C, triglyceride (TG) and low HDL-C.Although lipid and lipoprotein levels vary according to age and gender, acceptable, borderline high and high values have been determined for children.Dyslipidemia can occur for various reasons, such as dietary saturated and trans fats, consumption of refined carbohydrates and sugar, alcohol, medications, endocrine/metabolic/renal problems, infections and genetic factors.The frequency and duration of dyslipidemia screening are planned according to ag

APA, Harvard, Vancouver, ISO, and other styles

6

Pittman, Ray C., and Daniel Steinberg. "A Novel Mechanism by which High Density Lipoprotein Selectively Delivers Cholesterol Esters to the Liver." In Receptor-Mediated Uptake in the Liver. Springer Berlin Heidelberg, 1986. http://dx.doi.org/10.1007/978-3-642-70956-2_21.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

von Eckardstein, Arnold. "High Density Lipoproteins: Is There a Comeback as a Therapeutic Target?" In Prevention and Treatment of Atherosclerosis. Springer International Publishing, 2021. http://dx.doi.org/10.1007/164_2021_536.

Full text

Abstract:

AbstractLow plasma levels of High Density Lipoprotein (HDL) cholesterol (HDL-C) are associated with increased risks of atherosclerotic cardiovascular disease (ASCVD). In cell culture and animal models, HDL particles exert multiple potentially anti-atherogenic effects. However, drugs increasing HDL-C have failed to prevent cardiovascular endpoints. Mendelian Randomization studies neither found any genetic causality for the associations of HDL-C levels with differences in cardiovascular risk. Therefore, the causal role and, hence, utility as a therapeutic target of HDL has been questioned. Howev

APA, Harvard, Vancouver, ISO, and other styles

8

Murata, Masayuki. "Caveolin is a Cholesterol-binding Protein." In Lipoprotein Metabolism and Atherogenesis. Springer Japan, 2000. http://dx.doi.org/10.1007/978-4-431-68424-4_27.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Marcel, Yves L., Camilla A. Vézina, Philip K. Weech, François Tercé, and Ross W. Milne. "Lecithin: Cholesterol Acyltransferase, a Review and Immunochemical Studies." In Lipoprotein Deficiency Syndromes. Springer US, 1986. http://dx.doi.org/10.1007/978-1-4684-1262-8_15.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Haydn Pritchard, P., and Jiri Frohlich. "Apoprotein A-I and Lecithin: Cholesterol Acyltransferase in a Patient with Tangier Disease." In Lipoprotein Deficiency Syndromes. Springer US, 1986. http://dx.doi.org/10.1007/978-1-4684-1262-8_10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Lipoprotein(a)-cholesterol"

1

FATHIL, Noor Mahdi. "EFFECT OF THE ENERGY DRINK (TIGER) ON THE PARAMETERS OF LIPID PROFILEIN THE FEMALE ALBINO MICE." In III.International Scientific Congress of Pure,Appliedand Technological Sciences. Rimar Academy, 2021. http://dx.doi.org/10.47832/minarcongress3-5.

Full text

Abstract:

The aim of research is to clarify effect of an energy drink (Tiger) on Lipid profile physiological parameters in female mice for a period of four weeks. Adults female mice were used in research and divide to two groups. The first group is the control group that give distilled water (D.w.) for four weeks and the second group was treated group with tiger concentration dose 1.5 ml/mg for period of four weeks. After the end of the dosing period, sacrifices animals and the blood samples are collected without anticoagulant, and blood serum is obtained and kept at− 20 °C for biochemical tests. The re

APA, Harvard, Vancouver, ISO, and other styles

2

Mitropoulos, K. A., S. J. Walter, T. W. Meade, and M. P. Esnouf. "INCREASED FACTOR VII REACTIVITY IN THE RABBIT FOLLOWING DIET-INDUCED HYPERCHOIESTEROIAEMIA." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643802.

Full text

Abstract:

The association of factor VII coagulant activity (VIIC) with plasma lipid concentrations has been a consistent feature of a number of studies in man and points to plasma lipoproteins as determinants of VIIC.To modify plasma lipoprotein concentrations and to study the effect of this on VIIC, rabbits were fed a 1%- cholesterol-supplemented diet. Treatment resulted in a many-fold increase in plasma cholesterol concentration with the major fraction of excess cholesterol associated with the very low and intermediate density lipoprotein fractions. VIIC was considerably higher in rabbits fed 1%- chol

APA, Harvard, Vancouver, ISO, and other styles

3

Piraino, Francesco, Limary M. Cancel, Alberto Redaelli, and John M. Tarbell. "Effect of Simvastatin on the Apoptosis and Permeability of Endothelial Cell Monolayers." In ASME 2009 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2009. http://dx.doi.org/10.1115/sbc2009-206588.

Full text

Abstract:

Atherosclerosis is a chronic inflammatory response in the walls of arteries promoted by plasma proteins that carry cholesterol and triglycerides. The initiating event in atherosclerosis is the transport of low density lipoprotein (LDL) into the subendothelial space.

APA, Harvard, Vancouver, ISO, and other styles

4

Karpushina, A. V., A. G. Khotuleva, and O. V. Khokhlova. "LABORATORY PARAMETERS ASSOCIATED WITH CARDIOVASCULAR RISK ASSESSMENT IN ELECTRIC TRAIN DRIVERS." In The 4th «OCCUPATION and HEALTH» International Youth Forum (OHIYF-2022). FSBSI «IRIOH», 2022. http://dx.doi.org/10.31089/978-5-6042929-6-9-2022-1-105-109.

Full text

Abstract:

Introduction: Cardiovascular diseases are multifactorial, in its development occupational factors effects plays a significant role, and therefore it is important to optimize the prevention of cardiovascular pathology in workers, occupational factors taking into account. The aim of study was to evaluate laboratory parameters associated with cardiovascular risk in electric train drivers. Materials and methods: The study included 291 apparently healthy male train drivers of Moscow Metro aged from 45 to 59 years. Laboratory examination included the determination of the level of glucose, cholestero

APA, Harvard, Vancouver, ISO, and other styles

5

Pescador, R., R. Porta, R. Niada, M. Mantovani, and G. Prino. "DEFIBROTIDE DECREASES CHOLESTEROL CONTENT IN HYPERCHOLESTEROLEMIC RABBIT AORTA, WITH NO MODIFICATION OF PLASMA OR LIPOPROTEIN CHOLESTEROL." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643153.

Full text

Abstract:

Defibrotide was shown to stimulate the production of endogenous PGI2 from rat and hamster aortic tissue, as well as the production of PGi2 frcm the coronary vascular bed in the platelet perfused heart model. This effect was only seen in presence of platelets. Durirg the infusion period with Defibrotide thromboxane release remained unaffected while platelet cAMP rised. Defibrotide, was also able to reduce the secretion of ATP from platelets as well as to deaggregate platelet cluTps. It has been postulated that long-term administration of stable PGI^ metabolites or analogues could be a more usef

APA, Harvard, Vancouver, ISO, and other styles

6

Damirchi, Behzad, Amir Rouhollahi, Salman Sohrabi, and Seyyed Mahdi Nemati Mehr. "Modeling and Stability Analysis of Truncated High Density Lipoprotein (HDL) System Using Martini Coarse Grain Technique." In ASME 2013 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2013. http://dx.doi.org/10.1115/imece2013-64808.

Full text

Abstract:

Lipoproteins are biochemical compounds containing both proteins and lipids. These particles carry chemicals like cholesterol and triglycerides that are not soluble in aqueous solutions. This paper presents modeling of lipoprotein system using coarse grain molecular dynamics technique and stability analysis of this system in a water solution like blood. A high density lipoprotein (HDL) that consists of two annular monomers is modeled. Also there are lipid bilayers located in center of the rings, so the whole HDL and lipid bilayers are called lipoprotein system. First, all atom model is provided

APA, Harvard, Vancouver, ISO, and other styles

7

Prabhu, Anmiv S., Talukder Zaki Jubery, Kevin Freedman, Rafael Mulero, Prashanta Dutta, and Min Jun Kim. "High Throughput Nanofluidic Architectures for Nanoparticle Separation." In ASME 2009 International Mechanical Engineering Congress and Exposition. ASMEDC, 2009. http://dx.doi.org/10.1115/imece2009-10649.

Full text

Abstract:

High blood cholesterol levels and associated complications are a major health concern the world over and current techniques to deal with this, especially low density lipoprotein (LDL) apheresis, have significant room for improvement. We had previously reported a proof of concept technique that relies on silicon nitride based solid state nanopores to separate high density lipoprotein (HDL) like particles from LDL like particles. A mathematical model to describe the setup is reported. This model revealed that charge density of the pore surface was critical in determining the efficiency of separa

APA, Harvard, Vancouver, ISO, and other styles

8

Khirfan, G., M. Li, X. Wang, and G. A. Heresi. "Is Apolipoprotein A1 a Better Biomarker in Chronic Thromboembolic Pulmonary Hypertension Than High Density Lipoprotein Cholesterol?" In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3839.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Freyberg, J., S. Afzal, E. M. Landt, B. G. Nordestgaard, and M. Dahl. "Low-density lipoprotein-cholesterol and risk of chronic obstructive pulmonary disease: A prospective study of 107.301 participants." In ERS International Congress 2022 abstracts. European Respiratory Society, 2022. http://dx.doi.org/10.1183/13993003.congress-2022.4513.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Y. Al-Attar, Huda. "Serum Profiles of Some Minerals, Vitamin D and Lipids in Heart Diseases in Mosul City." In XII. International Scientific Congress of Pure, Applied and Technological Sciences. Rimar Academy, 2024. https://doi.org/10.47832/minarcongress12-07.

Full text

Abstract:

Vitamin D, a lipid-soluble vitamin that acts as a steroid hormone, can be acquired from dietary sources or manufactured in the skin upon exposure to ultraviolet (UV). it lacks is related to the presence of cardiovascular risk factors in adults which contributes to the high global prevalence of cardiovascular illnesses. For three months, 60 blood samples were collected from healthy people and patients with cardiovascular diseases, ranging in age from 25- 65 years, after which the lipid profile was analyzed, and found remarkable associations between the aforementioned minerals and total choleste

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Lipoprotein(a)-cholesterol"

1

Hung, Hsuan-Yu, Hui-Hsiung Lai, Hui-Chuan Lin, and Chung-Yu Chen. Impact of interferon-free antivirus therapy on lipid profiles in patients with chronic hepatitis C: A network meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.7.0055.

Full text

Abstract:

Review question / Objective: P: ("Hepatitis C"[Mesh] AND "Hepacivirus"[Mesh] AND "Hepatitis C, Chronic”[Mesh]) I: (direct acting antiviral OR asunaprevir OR boceprevir OR daclatasvir OR dasabuvir OR elbasvir OR glecaprevir OR grazoprevir OR ledipasvir OR ombitasvir OR paritaprevir OR pibrentasvir OR simeprevir OR sofosbuvir OR telaprevir OR velpatasvir OR voxilaprevir) C: placebo O: ( "Cholesterol, VLDL"[Mesh] OR "Cholesterol, LDL"[Mesh] OR "Cholesterol, HDL"[Mesh] OR "Dyslipidemias"[Mesh] OR "lipoprotein cholesterol ester, human" [Supplementary Concept] OR "lipoprotein cholesterol" [Supplemen

APA, Harvard, Vancouver, ISO, and other styles

2

Cheng, Wenke, Julia Boettner, Tina Fischer-Schaepman, et al. High-density lipoprotein Cholesterol Efflux Capacity and the Risk of Cardiovascular Diseases: A Systematic Review and Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.7.0006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Zhang, Guanwei, Jiajuan GUO, Hongguang Jin, et al. Association between extremely high-density lipoprotein cholesterol and adverse cardiovascular outcomes: A protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.3.0022.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Chaichanawongsaroj, Nuntaree. The role of exercise on serum lipid concentrations varies with Apo E genotype : a study in Thais subjects. Chulalongkorn University, 2004. https://doi.org/10.58837/chula.res.2004.76.

Full text

Abstract:

Apolipoprotein E (apo E) is one of several candidate genes involved in cardiovascular risk. However, the interaction between genes and environmental factors, such as exercise, dietary and lipid lowering intervention, may be affected the incidence of the disease. Our aim was to investigate the effect of physical activity (PA) and apo E polymorphism on plasma lipids and plasma glucose levels in 273 healthy, adult Thais. Plasma lipid and glucose concentrations were determined by enzymatic-colorimetric methods and apo E phenotypes by PCR-RFLP. A PA index was calculated from exercise data which ass

APA, Harvard, Vancouver, ISO, and other styles

5

Wang, Zhen, Alaa Al Nofal, Meera Shah, et al. Association of Digestible Carbohydrate Intake With Cardiovascular Disease, Type 2 Diabetes, Obesity, and Body Composition. Agency for Healthcare Research and Quality (AHRQ), 2025. https://doi.org/10.23970/ahrqepcsr_carbcardio.

Full text

Abstract:

Background. Epidemiological studies have shown inconsistent findings regarding the effect of dietary digestible carbohydrate intake on the risk of cardiovascular disease and type 2 diabetes (T2D). Synthesis of such evidence is important for determining the Dietary Reference Intakes (DRI) for carbohydrates, which can have consequences on incidence and morbidity of chronic conditions. Methods. Two systematic reviews were conducted, one addressing cardiovascular outcomes and the second addressing incidence of T2D, body weight, and composition. We searched several databases from January 1, 2000, t

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!